GBI roadshow next week and I imagine that they will release their presentation to the ASX.
Reluctant to anticipate what effect this will have on the SP as the environment is fairly sombre at present and there's an obvious overhang in this stock.
On top of recent Hologic bid for Thirdwave Technologies for US$580m, I note that Gen-Probe (GPRO) has just gazumped Solvay in its bid for Belgian based Innogenetics offering US$300m cash. Innogenetics has a HPV genotyping test that has been approved in Europe but not the US. GPRO's HPV test under development doesn't genotype as far as I know so may be fit for GPRO here.
Thirdwave and Innogenetics are the only 2 listed plays in the HPV space besides the big boys (Qiagen, Roche, Gen-Probe and Becton Dickinson) and so to see both the independent HPV plays under offer at the present time is surely a good sign.
GBI Price at posting:
0.0¢ Sentiment: ST Buy Disclosure: Held
